AI in Drug Discovery Market Size, Share, Trends & Forecast

The AI in Drug Discovery Market is expanding as pharmaceutical and biotechnology companies increasingly use artificial intelligence to accelerate research, analyze complex biological data, and identify promising drug candidates. Market Research Future estimates the market at USD 2.81 billion in 2025 and projects it to reach USD 23.95 billion by 2035, reflecting a CAGR of 23.9% during 2026–2035.

AI technologies can support multiple stages of drug discovery, including target identification, lead optimization, drug repurposing, preclinical testing, and clinical development. Machine learning and deep learning systems can analyze large datasets to identify relationships that may be difficult to detect using conventional approaches.

The growth of biomedical data is another major factor supporting adoption. Genomic, proteomic, molecular, and clinical datasets provide valuable inputs for AI models, allowing researchers to investigate potential drug targets and therapeutic candidates.

Pharmaceutical companies are increasingly collaborating with AI technology providers and biotechnology firms to strengthen their research capabilities. These partnerships can combine pharmaceutical expertise with computational modeling and advanced analytics.

As AI technologies continue to mature, their integration into pharmaceutical research is expected to create opportunities for faster and more data-driven drug discovery workflows.

Read More
Lukoon https://lukoon.com